Efficacy and tolerability of nanoparticle albumin-bound paclitaxel in combination with carboplatin as a late-phase chemotherapy for recurrent and advanced non-small-cell lung cancer: A multi-center study of the Fukushima lung cancer association group of surgeons

The present retrospective multi-center study aimed to evaluate the efficacy and feasibility of nanoparticle albumin-bound (nab)-paclitaxel plus carboplatin as a second or late-phase chemotherapy in patients with non-small cell lung cancer (NSCLC). A total of 25 patients with recurrent or advanced NS...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: Higuchi, Mitsunori, Takagi, Hironori, Owada, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Muto, Satoshi, Okabe, Naoyuki, Matsumura, Yuki, Hasegawa, Takeo, Yonechi, Atsushi, Osugi, Jun, Hoshino, Mika, Shio, Yutaka, Fujiu, Koichi, Kanno, Ryuzo, Ohishi, Akio, Suzuki, Hiroyuki, Gotoh, Mitsukazu
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2017
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5453047/
https://ncbi.nlm.nih.gov/pubmed/28599432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5998
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires